In June 2021, RedCloud Bio secured investment of RMB 100 million in a Series B financing led by Co-Win Ventures, participated by Kaitai Capital. Sherpa Healthcare Partners, Dayou Capital and Dynamic BalanceInvestment Management also contributed to the Series B round.
In November 2019, The Company received a Series A financing from Dayou Capital and Sherpa Healthcare Partners.
Contact Us
Nanjing |307-311, Building No.9, 669-8 Xuanwu Avenue, Xuanwu District
Shanghai|Suite 901, 880 Xiangyang Road, Minhang District
Beijing |Suite 205, Building No.2, PKUCare Industrial Park, Changping District
Website: https://www.redcloudbio.com